Mallinckrodt (MNK) Tops Q3 EPS by 30c, Revenues Beat; Offers FY18 EPS Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Mallinckrodt (MNK) Tops Q3 EPS by 30c, Revenues Beat; Offers FY18 EPS Guidance Above Consensus

Mallinckrodt plc Reports Third Quarter 2018 Results and Raises Earnings Guidance for 2018

November 6, 2018 6:00 AM EST

STAINES-UPON-THAMES, United Kingdom, Nov. 6, 2018 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the three months ended September 28, 2018. Unless otherwise noted, the quarter comparisons are to the prior year comparable three months ended September 29, 2017.

Net sales were $640.0 million in the quarter as compared to $600.6... More